ES414411A1 - Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano. - Google Patents

Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano.

Info

Publication number
ES414411A1
ES414411A1 ES0414411A ES414411A ES414411A1 ES 414411 A1 ES414411 A1 ES 414411A1 ES 0414411 A ES0414411 A ES 0414411A ES 414411 A ES414411 A ES 414411A ES 414411 A1 ES414411 A1 ES 414411A1
Authority
ES
Spain
Prior art keywords
steroids
translation
procedure
preparation
machine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0414411A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES414411A1 publication Critical patent/ES414411A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
ES0414411A 1972-05-05 1973-05-04 Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano. Expired ES414411A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
ES414411A1 true ES414411A1 (es) 1976-02-01

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0414411A Expired ES414411A1 (es) 1972-05-05 1973-05-04 Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano.

Country Status (16)

Country Link
JP (1) JPS4961150A (de)
AT (1) AT355232B (de)
AU (1) AU475168B2 (de)
BE (1) BE799102A (de)
CA (1) CA1013341A (de)
CH (1) CH617710A5 (de)
DE (1) DE2322532A1 (de)
ES (1) ES414411A1 (de)
FR (1) FR2183792B1 (de)
GB (1) GB1430942A (de)
IE (1) IE37596B1 (de)
IL (1) IL42196A (de)
LU (1) LU67546A1 (de)
NL (1) NL7306234A (de)
SE (1) SE400771B (de)
ZA (1) ZA733035B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5939545A (en) * 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
ES2296594T3 (es) * 1994-02-14 2008-05-01 Euro-Celtique S.A. Androstanos y pregnanos para la modulacion alosterica del receptor de gaba.
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
EP3572417B1 (de) 2011-10-14 2025-12-17 Sage Therapeutics, LLC 3,3-disubstituierte 19-nor-pregnan verbindungen, zusammensetzungen damit und verwendungen davon
EP2806877B2 (de) 2012-01-23 2025-01-29 Sage Therapeutics, Inc. Neuroaktive steroid-formulierungen mit einem komplex aus allopregnanolon und sulfobutylether beta-cyclodextrin
CA2882708A1 (en) 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
KR102396328B1 (ko) 2013-04-17 2022-05-10 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
EP2986624B1 (de) 2013-04-17 2020-03-25 Sage Therapeutics, Inc. Neuroaktive 19-nor-steroide zur verwendung zur behandlung von krankheiten
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
ME03809B (de) 2014-10-16 2021-04-20 Sage Therapeutics Inc Zusammensetzungen und verfahren zur behandlung von störungen des zentralen nervensystems
CN117024501A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
EP4155314A1 (de) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Neuroaktive steroide, zusammensetzungen und verwendungen davon
KR20240157128A (ko) 2016-03-08 2024-10-31 세이지 테라퓨틱스, 인크. 신경활성 스테로이드, 조성물, 및 그의 용도
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
WO2018013615A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
SG11202112391UA (en) 2019-05-31 2021-12-30 Sage Therapeutics Inc Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
FR2183792B1 (de) 1977-07-15
JPS4961150A (de) 1974-06-13
AU5528473A (en) 1974-11-07
IE37596L (en) 1973-11-05
CH617710A5 (en) 1980-06-13
CA1013341A (en) 1977-07-05
AT355232B (de) 1980-02-25
FR2183792A1 (de) 1973-12-21
DE2322532A1 (de) 1973-11-22
IL42196A (en) 1978-10-31
NL7306234A (de) 1973-11-07
ZA733035B (en) 1974-04-24
LU67546A1 (de) 1973-07-13
ATA395173A (de) 1979-07-15
SE400771B (sv) 1978-04-10
GB1430942A (en) 1976-04-07
IE37596B1 (en) 1977-08-31
IL42196A0 (en) 1973-07-30
BE799102A (fr) 1973-11-05
AU475168B2 (en) 1976-08-12

Similar Documents

Publication Publication Date Title
ES414411A1 (es) Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano.
ES421253A1 (es) Un procedimiento para la preparacion de nuevos 11,11-alco- hiliden-esteroides.
NL170420C (nl) Werkwijze voor het bereiden van corticoide steroiden en voor een corticoide steroide bevattend preparaat, alsmede gevormd farmaceutisch preparaat.
DK139031B (da) Analogifremgangsmåde til fremstilling af i 21-stillingen alkylerede 3,20-dioxo-delta4-steroider af pregnanrækken.
ES439952A1 (es) Un procedimiento para la preparacion de d-homoesteroides de la serie del pregnano.
CH612686A5 (en) Process for the preparation of steroids of the androstane series
ES414508A1 (es) Procedimiento de fabricacion de un compuesto de accion hi- polipemiante.
ES414412A1 (es) Procedimiento para la preparacion de esteroides de las series del pregnano o del 19-norpregnano.
BG33737A3 (bg) Метод за получаване на заместени в 17-та позиция стероиди от прегнановия ред
ES407142A1 (es) Procedimiento para la obtencion de n-(1-etil-alfa-pirroli- dilmetil) - 2 - metoxi - 5-sulfamidobenzamida.
ES412235A1 (es) Procedimiento para producir acetatos.
DK138544B (da) Analogifremgangsmåde til fremstilling af 2beta,6beta,16beta-triamino-3alfa,5alfa,17beta-trihydroxyandrostan-derivater eller syreadditionssalte eller di- eller trikvaternære salte deraf.
ES319114A1 (es) Un procedimiento de preparacion de los 21-hidroxi esteroides de la serie del pregnano esterificados en la posicion 21.
CA1034521A (en) PROCESS FOR THE PREPARATION OF 17-ACYL ESTERS OF 17.alpha.,21-DIHYDROXYSTEROIDS OF THE PREGNANE SERIES
ES429338A1 (es) Procedimiento para la preparacion del esteroide 21-acetato de 16-alfa,17-alfa-ciclopentilidendioxi-3,20-oliona
ES455933A1 (es) Procedimiento para la preparacion de nuevos esteroides.
ES444637A1 (es) Procedimiento de preparacion de derivados de esteroides.
ES397035A1 (es) Un procedimiento para preparar un coprecipitado de un agen-te antiinflamatorio y un lignosulfato.
ES382098A1 (es) Procedimiento para la preparacion de nuevas 14 beta-hidro- xi-15 alfa-aciloxi-cardenolidas.
SE7601753L (sv) Sett att framstella 3-enoletrar av 11beta-hydroxi-delta?724-pregnen-3-oner och derivat derav
IE37597L (en) 21-fluoro pregnanes.
NL7309756A (en) C-17-C-3' disteroidyl-ethers - show improved and roll-anabolic, progestational anticonceptional, anti-inflammatory activity
ES383319A1 (es) Un procedimiento para la preparacion de derivados esteroi- dales terapeuticamente importantes y nuevos compuestos in- termedios utiles en este procedimiento.
GB1008273A (de)
FR2108537A5 (en) 2-haloalkyl-5-phenyl-1,3,4-oxiadiazoles prepn - from haloalkanoic acids phenyl acid hydrazides and a mineral acid halide